CytomX Therapeutics, Inc. Shares Outstanding (Cover Page)
CytomX Therapeutics, Inc. (CTMX) had Shares Outstanding (Cover Page) of 217.90 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 217.90M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 217.70M shares.
- 2025-12-31: Entity Common Stock, Shares Outstanding 170.19M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 169.44M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 217.90M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 217.70M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 170.19M shares 10-K · filed 2026-03-16 |
| 2025-10-31 | 169.44M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 164.91M shares 10-Q · filed 2025-08-07 |
| 2025-04-30 | 80.62M shares 10-Q · filed 2025-05-12 |
| 2025-02-28 | 80.10M shares 10-K · filed 2025-03-06 |
| 2024-10-31 | 78.26M shares 10-Q · filed 2024-11-07 |
| 2024-07-29 | 78.12M shares 10-Q · filed 2024-08-08 |
| 2024-02-29 | 67.72M shares 10-K · filed 2024-03-11 |
| 2023-10-31 | 66.99M shares 10-Q · filed 2023-11-07 |
| 2023-07-31 | 66.77M shares 10-Q · filed 2023-08-08 |
| 2023-04-30 | 66.34M shares 10-Q · filed 2023-05-09 |
| 2023-02-28 | 66.23M shares 10-K · filed 2023-03-27 |
| 2022-10-31 | 66.08M shares 10-Q · filed 2022-11-08 |
| 2022-07-29 | 65.95M shares 10-Q · filed 2022-08-04 |
| 2022-04-29 | 65.40M shares 10-Q · filed 2022-05-05 |
| 2022-01-31 | 65.39M shares 10-K/A · filed 2023-03-27 |
| 2021-10-31 | 65.25M shares 10-Q · filed 2021-11-04 |
| 2021-07-31 | 65.16M shares 10-Q · filed 2021-08-05 |
| 2021-04-30 | 65.01M shares 10-Q · filed 2021-05-06 |
| 2021-02-02 | 64.78M shares 10-K · filed 2021-02-24 |
| 2020-10-31 | 46.22M shares 10-Q · filed 2020-11-05 |
| 2020-07-31 | 46.19M shares 10-Q · filed 2020-08-06 |
| 2020-04-30 | 45.92M shares 10-Q · filed 2020-05-07 |
| 2020-01-31 | 45.57M shares 10-K · filed 2020-02-27 |
| 2019-10-31 | 45.43M shares 10-Q · filed 2019-11-07 |
| 2019-07-31 | 45.41M shares 10-Q · filed 2019-08-07 |
| 2019-04-30 | 45.31M shares 10-Q · filed 2019-05-09 |
| 2019-01-31 | 45.11M shares 10-K · filed 2019-02-27 |
| 2018-11-02 | 45.01M shares 10-Q · filed 2018-11-06 |
| 2018-08-06 | 44.96M shares 10-Q · filed 2018-08-08 |
| 2018-05-07 | 38.96M shares 10-Q · filed 2018-05-09 |
| 2018-03-05 | 38.61M shares 10-K · filed 2018-03-07 |
| 2017-11-03 | 38.41M shares 10-Q · filed 2017-11-07 |
| 2017-08-04 | 36.87M shares 10-Q · filed 2017-08-07 |
| 2017-05-03 | 36.75M shares 10-Q · filed 2017-05-05 |
| 2017-02-28 | 36.52M shares 10-K · filed 2017-03-02 |
| 2016-11-01 | 36.40M shares 10-Q · filed 2016-11-03 |
| 2016-08-01 | 36.29M shares 10-Q · filed 2016-08-03 |
| 2016-05-04 | 36.09M shares 10-Q · filed 2016-05-06 |
| 2016-03-02 | 36.08M shares 10-K · filed 2016-03-07 |
| 2015-11-19 | 36.02M shares 10-Q · filed 2015-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |